| Bioactivity | PROTAC BRD9 Degrader-7 is an orally active and selective degrader of BRD9 with a DC50 of 1.02 nM. PROTAC BRD9 Degrader-7 has superior oral activity with a Cmax of 3436.95 ng/mL[1]. |
| Name | PROTAC BRD9 Degrader-7 |
| Formula | C36H35N5O7 |
| Molar Mass | 649.69 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Jingyu Zhang, et al. Structure-based identification of new orally bioavailable BRD9-PROTACs for treating acute myelocytic leukemia, European Journal of Medicinal Chemistry, Volume 262, 2023, 115872. |
PROTAC BRD9 Degrader-7
CAS: F: C36H35N5O7 W: 649.69
PROTAC BRD9 Degrader-7 is an orally active and selective degrader of BRD9 with a DC50 of 1.02 nM. PROTAC BRD9 Degrader-7
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.